Cite
HARVARD Citation
Volkmann, E. et al. (n.d.). SAT0157 NINTEDANIB DOSE ADJUSTMENTS AND ADVERSE EVENTS IN PATIENTS WITH PROGRESSIVE AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASES IN THE INBUILD TRIAL. Annals of the rheumatic diseases. p. 1019. [Online].